secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ventyx Biosciences, Inc. (—)
CIK:        0001851194
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001193125-24-210399
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ventyx CFO Martin D. Auster departs; Roy Gonzales appointed interim CFO/PAO
---------------------------------------------------------------------------

- Appointed Roy M. Gonzales as interim principal financial officer and interim principal accounting officer effective Aug 30, 2024, replacing Martin D. Auster.
- Dr. Auster's separation agreement provides nine months base salary continuation, COBRA reimbursement, and accelerated vesting of equity vesting within three months.
- Gonzales joined as SVP of Finance in April 2024; previously VP of Accounting; salary $350k, 30% target bonus.
- No changes to Gonzales' compensation or terms from his interim appointment.
- No family relationships or material transactions with Gonzales requiring disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851194/000119312524210399/0001193125-24-210399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851194/000119312524210399/d884852d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-210399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer